Moreover, in AD animal models, either β-amyloid oligomers or AD-associated toxins initiate the elevation of phosphorylated Eif2α, neuronal insulin receptor substrate inhibition, synapse loss, and cognition impairment through activating PKR (Lourenco et al., 2013). Here, INSR is linked to Alzheimer disease.